315 Exposes "Exosome" Chaos: Involved Enterprise Lisai Pharmaceuticals Was Previously Fined 220,000 Yuan, Company's National Service Hotline Goes Unanswered

MaticHoleFiller · 2026-03-18T07:03:51+00:00

Hunan Lirsai Pharmaceutical Co., Ltd. was called out for its exosome problems exposed by the CCTV 3.15 evening program. The company was established in 2021 and focuses on OEM/ODM for high-end medical devices. It was previously penalized for violating medical device management regulations. The company's phone line goes unanswered.

MaticHoleFiller

2026-03-18 07:03:51

Abstract generation in progress

Investing in stocks? Rely on Golden Kylin Analyst Reports—authoritative, professional, timely, comprehensive—helping you discover potential thematic opportunities!

March 15 evening news: CCTV’s 3.15 Gala exposed the “all-purpose” exosome issue, and Hunan Lise Pharmaceutical Co., Ltd. was named.

Tianyancha app shows that Hunan Lise Pharmaceutical Co., Ltd. was established in June 2021. The legal representative is Xiao Jingyang, with a registered capital of 3 million RMB. Its business scope includes medical device technology development, management of health medical industry projects, and more, operated by Xiao Shuang and Xiao Jingyang. Administrative penalty information indicates that in June 2025, the company was fined over 220,000 RMB by the Hunan Provincial Drug Administration for violations of the “Medical Device Supervision and Administration Regulations.”

According to the company’s official website, Hunan Lise Pharmaceutical is located in Changsha, Hunan, with an operational center in Guangzhou Meibo City. It specializes in OEM/ODM of high-end Class II medical devices, covering various high-end medical device products. These can be supplied directly to hospitals and pharmacies, with platform authorization, professional OEM/ODM services, and Class II medical device registration numbers: anti-HPV gel dressings, medical gynecological gels, recombinant type III humanized collagen liquid dressings, recombinant type III humanized collagen gel dressings, recombinant type III humanized collagen patches, scar repair dressings, etc., all approved by the national drug supervision authority.

The “BUG” segment called the nationwide service hotline of Hunan Lise Pharmaceutical Co., Ltd. (the same as the business registration phone), but no one answered.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.